Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.

Panaccione R, Chan-Diehl F, Baygani S, Fisher DA, Moses RE, Siegmund B, Walsh A, Kobayashi T, Dulai PS, Travis S.

Open source

DOI
10.1093/crocol/otaf043
Published
2025-04-01
Container
Crohns Colitis 360
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/crocol/otaf043,
  title = {Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.},
  author = {Panaccione R and  Chan-Diehl F and  Baygani S and  Fisher DA and  Moses RE and  Siegmund B and  Walsh A and  Kobayashi T and  Dulai PS and  Travis S.},
  year = {2025},
  journal = {Crohns Colitis 360},
  doi = {10.1093/crocol/otaf043},
  url = {https://doi.org/10.1093/crocol/otaf043}
}

RIS

TY  - JOUR
TI  - Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.
AU  - Panaccione R
AU  -  Chan-Diehl F
AU  -  Baygani S
AU  -  Fisher DA
AU  -  Moses RE
AU  -  Siegmund B
AU  -  Walsh A
AU  -  Kobayashi T
AU  -  Dulai PS
AU  -  Travis S.
PY  - 2025
JO  - Crohns Colitis 360
DO  - 10.1093/crocol/otaf043
UR  - https://doi.org/10.1093/crocol/otaf043
ER  - 

APA

R, P., F, C., S, B., DA, F., RE, M., B, S., A, W., T, K., PS, D., & S., T. (2025). Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis.. Crohns Colitis 360. https://doi.org/10.1093/crocol/otaf043

Source records